WSJ News Exclusive | McDonald’s Pushes Diners to Use Trays as Food Bags Run Tight

United States News News

WSJ News Exclusive | McDonald’s Pushes Diners to Use Trays as Food Bags Run Tight
United States Latest News,United States Headlines
  • 📰 WSJ
  • ⏱ Reading Time:
  • 50 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 63%

McDonald’s recently told restaurant owners that they needed to limit orders of bags from suppliers as usage is running ahead of already high numbers last year

Burger lovers will have to get used to eating off fast-food trays inside McDonald’s again.latest supply challenge affecting U.S. restaurants

. The chain recently told restaurant owners that they needed to limit orders of bags from suppliers as usage is running ahead of already high numbers last year, McDonald’s said in an internal message. Many customers are asking for their Big Macs, McNuggets and fries in bags even when they dine inside, driving the tightness, the chain said in the message. Workers who have spent months packing all orders to go during the pandemic aren’t used to serving meals on trays, contributing to the strain, the company said.

“Many new crew members have never had to deal with trays before,” the company said in the late-July message. The “transition to using trays has been slower, more difficult because we haven’t done it in so long.” McDonald’s said that while bag supplies have been pressured for the chain and others in the industry, impact to its restaurants was minimal. “We are confident customers should not see disruption,” the company said. “We will continue to watch closely.”

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

WSJ /  🏆 98. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

WSJ News Exclusive | FDA Covid-19 Vaccine Booster Plan Could Be Ready Within WeeksWSJ News Exclusive | FDA Covid-19 Vaccine Booster Plan Could Be Ready Within WeeksThe FDA expects to have a strategy on Covid-19 vaccine boosters by early September that would lay out when and which individuals should get the follow-up shots, according to people familiar with discussions of the matter
Read more »

WSJ News Exclusive | Joe Manchin Says Fed Should Reverse Easy-Money PoliciesWSJ News Exclusive | Joe Manchin Says Fed Should Reverse Easy-Money PoliciesSen. Joe Manchin raised alarms about inflation in a letter to Fed Chairman Jerome Powell on Thursday, calling on the central bank to start reversing the emergency support it has provided during the pandemic
Read more »

WSJ News Exclusive | Senate Bill to Repeal Iraq War Authorizations Draws Key Level of GOP SupportWSJ News Exclusive | Senate Bill to Repeal Iraq War Authorizations Draws Key Level of GOP SupportTen Republican senators have signed on as co-sponsors of a bipartisan bill to repeal the 1991 and 2002 authorizations for use of military force in Iraq, a key threshold needed to overcome a Senate filibuster
Read more »

WSJ News Exclusive | Business Groups Call on Biden to Restart Trade Talks With ChinaWSJ News Exclusive | Business Groups Call on Biden to Restart Trade Talks With ChinaNearly three dozen of the nation’s most influential business groups are calling on the Biden administration to cut tariffs on Chinese imports, saying they are a drag on the U.S. economy.
Read more »

WSJ News Exclusive | China’s Antitrust Regulator Planning to Fine Meituan About $1 BillionWSJ News Exclusive | China’s Antitrust Regulator Planning to Fine Meituan About $1 BillionThe State Administration for Market Regulation is preparing to impose a roughly $1 billion fine on food-delivery giant Meituan for allegedly abusing its dominant market position, according to people familiar with the matter
Read more »

WSJ News Exclusive | SPAC Backed by Corvex, Casdin Near Deal for Drug-Price Startup EQRxWSJ News Exclusive | SPAC Backed by Corvex, Casdin Near Deal for Drug-Price Startup EQRxEQRx has developed medicines that mimic the biological function of existing drugs but have molecular structures distinct enough that they don’t infringe on patents of brand-name drug manufacturers.
Read more »



Render Time: 2025-03-13 22:22:13